Page Image

Nephrology Times

Nephrology Times delivers the latest news in kidney-related treatments and technologies with the goal of better informing care decisions and improving patient outcomes.

Higher Risk for Negative Kidney End Points, ESRD With Crescents in IgAN
A review and meta-analysis revealed an association between crescents and worsened renal outcomes in patients with IgAN.
Advertisement

Latest News

Sponsored Content

The Role of BAFF and APRIL in IgA Nephropathy

A large, long-term outcomes study of UK patients with IgA nephropathy (IgAN) revealed that patients with low proteinuria levels faced significant risks of kidney failure. This underscores the limitations of supportive care regimens, which primarily seek to manage chronic kidney disease but fail to address the specific underlying mechanism of IgAN, leaving a high lifetime risk of end-stage kidney disease. Learn about the pathogenic role of B cells and their cytokine drivers, BAFF and APRIL — potential therapeutic targets specific to IgAN and other autoimmune kidney diseases.

Advertisement

In Print

Conferences

Podcasts

Expert Columns

Advertisement
Advertisement
Editorial Board